US Broker Ratings

Option Care Health, Inc. (OPCH) Stock Analysis: A 42% Upside Potential Amidst Strong Buy Ratings

Option Care Health, Inc. (NASDAQ: OPCH), a dominant player in the U.S. healthcare sector, is drawing significant investor attention with its robust service offerings in home and alternate site infusion..

Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 26% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector might find Teleflex Incorporated (NYSE: TFX) an intriguing prospect, particularly given its potential upside of 26.38%. With a market cap of $4.66 billion,..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unpacking a 41.77% Potential Upside for Investors

Investors eyeing the healthcare sector may want to take a closer look at Axsome Therapeutics, Inc. (NASDAQ: AXSM), a burgeoning player in the biotechnology industry. With a market capitalization of..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a Potential 52.90% Upside

Investors keen on the healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect. With a current market capitalization of $3.96 billion, the company operates within the..

Waters Corporation (WAT) Investor Outlook: Analyzing the 33% Potential Upside Driven by Strong Analyst Ratings

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, particularly within the Diagnostics & Research industry. With a market cap of $29.33 billion, Waters Corporation has..

Viatris Inc. (VTRS) Stock Analysis: Navigating a Complex Healthcare Landscape with a 17% Potential Upside

Viatris Inc. (VTRS), a prominent player in the healthcare sector, is forging a path through the complex landscape of drug manufacturing with a focus on both specialty and generic products...

AstraZeneca PLC (AZN) Stock Analysis: Evaluating Growth Potential Amid a 13.53% Upside

AstraZeneca PLC (NASDAQ: AZN), a leading player in the healthcare sector, is drawing investor attention with a market capitalization of $284.63 billion and a strong presence in the biopharmaceutical landscape...

Alcon Inc. (ALC)

⚠️ No article content returned.

..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Healthcare Innovator with 20.62% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable force in the biotechnology sector, particularly within the healthcare industry. With its headquarters in Boston, Massachusetts, Vertex is renowned for delivering..

AptarGroup, Inc. (ATR) Stock Analysis: Capitalize on a 34.64% Potential Upside in the Growing Healthcare Sector

Investors seeking opportunities in the healthcare sector should closely examine AptarGroup, Inc. (NYSE: ATR), a leader in the design and manufacturing of drug delivery and consumer product dispensing solutions. With..

Revolution Medicines (RVMD) Stock Analysis: A Look at the 39.59% Potential Upside in Precision Oncology

Investors are turning their attention to Revolution Medicines, Inc. (NASDAQ: RVMD), a trailblazer in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $18.98 billion, this..

BeOne Medicines Ltd. (ONC) Stock Analysis: Biotechnology Innovator with a 49% Upside Potential

BeOne Medicines Ltd. (NASDAQ: ONC), a prominent player in the biotechnology sector, has caught the attention of investors with its substantial growth potential. Based in Basel, Switzerland, this oncology-focused company..

Takeda Pharmaceutical Company L (TAK): Investor Outlook on a 9.71% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the pharmaceutical industry, commands attention with its robust market presence and innovative drug portfolio. With a market capitalization of $56.33 billion,..

Charles River Laboratories (CRL) Stock Analysis: Exploring a 28.56% Potential Upside

Investors eyeing opportunities in the healthcare sector might find Charles River Laboratories International, Inc. (NYSE: CRL) an enticing prospect, especially given its significant potential upside. With an average target price..

Masimo Corporation (MASI) Stock Analysis: Navigating Healthcare Innovation with Strong Revenue Growth

Masimo Corporation (NASDAQ: MASI), a stalwart in the healthcare sector, particularly within the medical devices industry, continues to capture investor attention with its innovative approach to patient monitoring technologies. Headquartered..

BioNTech SE (BNTX) Stock Analysis: Navigating a 48% Potential Upside Amidst Volatile Financials

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has garnered significant attention from investors worldwide, particularly for its pioneering work in developing immunotherapies and mRNA vaccines. With..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating a Potential 44.57% Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, specializes in providing mission-critical products and services across a diverse range of industries including biopharma, healthcare, education, and advanced..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 46% Potential Upside in the Healthcare Sector

Grifols, S.A. (NYSE: GRFS), a major player in the healthcare sector, has caught the attention of investors with its promising potential for significant upside. With a current stock price of..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating a 26% Potential Upside in Healthcare

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, particularly within the medical care facilities industry. This German-based company, with a market capitalization of..

IDEXX Laboratories, Inc. (IDXX) Stock Report: Evaluating a 29.96% Potential Upside in the Diagnostics Leader

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the diagnostics and research sector, is making waves in the healthcare industry with its innovative solutions for veterinary and water quality..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds